Literature DB >> 24890961

Influenza epidemiology, vaccine coverage and vaccine effectiveness in sentinel Australian hospitals in 2012: the Influenza Complications Alert Network (FluCAN).

Allen C Cheng1, Simon Brown2, Grant Waterer2, Mark Holmes3, Sanjaya Senenayake4, N Deborah Friedman5, Saliya Hewagama6, Graham Simpson7, Peter Wark8, John Upham9, Tony Korman10, Dominic Dwyer11, Richard Wood-Baker12, Louis Irving13, Simon Bowler14, Tom Kotsimbos1, Paul Kelly15.   

Abstract

Influenza is mostly a mild, self-limiting infection and severe infection requiring hospitalisation is uncommon. Immunisation aims to reduce serious morbidity and mortality. The Influenza Complications Alert Network (FluCAN) is a sentinel hospital-based surveillance program that operates at 15 sites across all states and territories in Australia. This study reports on the epidemiology of hospitalisation with confirmed influenza, estimate vaccine coverage and influenza vaccine protection against hospitalisation with influenza during the 2012 influenza season. In this observational study, cases were defined as patients admitted to one of the sentinel hospitals with influenza confirmed by nucleic acid detection. Controls were patients who had acute respiratory illnesses who were test-negative for influenza. Vaccine effectiveness was estimated as 1 minus the odds ratio of vaccination in case patients compared with control patients, after adjusting for known confounders. During the period 9 April to 31 October 2012, 1,231 patients were admitted with confirmed influenza at the 15 FluCAN sentinel hospitals. Of these, 47% were more than 65 years of age, 8% were Indigenous Australians, 3% were pregnant and 76% had chronic co-morbidities. Influenza A was detected in 83% of patients. Vaccination coverage was calculated from the vaccination status of 1,216 test negative controls and was estimated at 77% in patients 65 years or over and 61% in patients with chronic comorbidities. Vaccination effectiveness was estimated at 41% (95% CI: 28%, 51%, P<0.001). Vaccine coverage was incomplete in at-risk groups, particularly non-elderly patients with medical comorbidities. The study results suggest that the seasonal influenza vaccine was moderately protective against hospitalisation with influenza during the 2012 season. This work is copyright. Apart from any use as permitted under the Copyright Act 1968, no part may be reproduced by any process without prior written permission from the Commonwealth. Requests and inquiries concerning reproduction and rights should be addressed to the Commonwealth Copyright Administration, Attorney General's Department, Robert Garran Offices, National Circuit, Barton ACT 2600 or posted at http://www.ag.gov.au/cca.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24890961

Source DB:  PubMed          Journal:  Commun Dis Intell Q Rep        ISSN: 1447-4514


  9 in total

1.  Influenza vaccine effectiveness by test-negative design - Comparison of inpatient and outpatient settings.

Authors:  Shuo Feng; Benjamin J Cowling; Sheena G Sullivan
Journal:  Vaccine       Date:  2016-02-23       Impact factor: 3.641

2.  The Use of Test-negative Controls to Monitor Vaccine Effectiveness: A Systematic Review of Methodology.

Authors:  Huiying Chua; Shuo Feng; Joseph A Lewnard; Sheena G Sullivan; Christopher C Blyth; Marc Lipsitch; Benjamin J Cowling
Journal:  Epidemiology       Date:  2020-01       Impact factor: 4.822

3.  The Importance of Frailty in the Assessment of Influenza Vaccine Effectiveness Against Influenza-Related Hospitalization in Elderly People.

Authors:  Melissa K Andrew; Vivek Shinde; Lingyun Ye; Todd Hatchette; François Haguinet; Gael Dos Santos; Janet E McElhaney; Ardith Ambrose; Guy Boivin; William Bowie; Ayman Chit; May ElSherif; Karen Green; Scott Halperin; Barbara Ibarguchi; Jennie Johnstone; Kevin Katz; Joanne Langley; Jason Leblanc; Mark Loeb; Donna MacKinnon-Cameron; Anne McCarthy; Allison McGeer; Jeff Powis; David Richardson; Makeda Semret; Grant Stiver; Sylvie Trottier; Louis Valiquette; Duncan Webster; Shelly A McNeil
Journal:  J Infect Dis       Date:  2017-08-15       Impact factor: 5.226

Review 4.  Effectiveness of influenza vaccines in preventing severe influenza illness among adults: A systematic review and meta-analysis of test-negative design case-control studies.

Authors:  Marc Rondy; Nathalie El Omeiri; Mark G Thompson; Alain Levêque; Alain Moren; Sheena G Sullivan
Journal:  J Infect       Date:  2017-09-18       Impact factor: 6.072

5.  Efficacy of influenza vaccine (Fluvax) in cancer patients on treatment: a prospective single arm, open-label study.

Authors:  A Ayoola; S Sukumaran; K Jain; R Kumar; D Gordon; Y Honda-Okubo; S Quinn; A Roy; S Vatandoust; B Koczwara; G Kichenadasse; A Richards; K Mead; C Karapetis
Journal:  Support Care Cancer       Date:  2020-03-07       Impact factor: 3.603

6.  Retrospective forecasting of the 2010-2014 Melbourne influenza seasons using multiple surveillance systems.

Authors:  R Moss; A Zarebski; P Dawson; J M McCAW
Journal:  Epidemiol Infect       Date:  2016-09-27       Impact factor: 4.434

7.  Influenza vaccine effectiveness in preventing influenza A(H3N2)-related hospitalizations in adults targeted for vaccination by type of vaccine: a hospital-based test-negative study, 2011-2012 A(H3N2) predominant influenza season, Valencia, Spain.

Authors:  Joan Puig-Barberà; Juan García-de-Lomas; Javier Díez-Domingo; Alberto Arnedo-Pena; Montserrat Ruiz-García; Ramón Limón-Ramírez; Silvia Pérez-Vilar; José Luis Micó-Esparza; Miguel Tortajada-Girbés; Concha Carratalá-Munuera; Rosa Larrea-González; Juan Manuel Beltrán-Garrido; Maria Del Carmen Otero-Reigada; Joan Mollar-Maseres; Patricia Correcher-Medina; Germán Schwarz-Chavarri; Vicente Gil-Guillén
Journal:  PLoS One       Date:  2014-11-13       Impact factor: 3.240

8.  2012-2013 Seasonal influenza vaccine effectiveness against influenza hospitalizations: results from the global influenza hospital surveillance network.

Authors:  Joan Puig-Barberà; Angels Natividad-Sancho; Odile Launay; Elena Burtseva; Meral A Ciblak; Anita Tormos; Amparo Buigues-Vila; Sergio Martínez-Úbeda; Anna Sominina
Journal:  PLoS One       Date:  2014-06-19       Impact factor: 3.240

9.  Influenza and pneumococcal vaccination in Australian adults: a systematic review of coverage and factors associated with uptake.

Authors:  Amalie Dyda; Surendra Karki; Andrew Hayen; C Raina MacIntyre; Robert Menzies; Emily Banks; John M Kaldor; Bette Liu
Journal:  BMC Infect Dis       Date:  2016-09-26       Impact factor: 3.090

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.